Date & Time
Wednesday, October 28, 2026, 10:00 AM - 10:30 AM
Name
477a Implementing Buprenorphine-Naloxone for Opioid Use Disorder in Adolescents*
Description
Youth with opioid use disorder need treatment approaches tailored to adolescent development and correctional environments. This session examines the implementation of an OUD program across a statewide juvenile corrections system. Explore buprenorphine-naloxone induction, withdrawal management, interdisciplinary collaboration, and practical strategies that help organizations build institutional support for evidence-based treatment.
Educational Objectives
- Summarize evidence supporting MOUD implementation in adolescent correctional care
- Identify acute opioid withdrawal and management strategies
- Discuss medications used to manage acute opioid withdrawal and opioid use disorder
Level: Advanced
Speakers